FDA Inspection 1092259 — Amit (Nmi)Mahipal MD
The FDA completed an inspection of Amit (Nmi)Mahipal MD on May 21, 2019 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 21, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, MN (United States)
Additional details
Clinical Investigator (CI)